Seeking Alpha

Novartis' (NVS +0.3%) RLX030 drug cut the number of deaths in patients with acute heart failure...

Novartis' (NVS +0.3%) RLX030 drug cut the number of deaths in patients with acute heart failure in a Phase III trial. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)